---
figid: PMC5746415__oncotarget-08-110693-g001
figlink: /pmc/articles/PMC5746415/figure/F1/
number: Figure 1
caption: The inhibitors against target molecules are indicated, which could enhance
  antitumor responses in in mouse models when combined with PD-1/PD-L1 blockade.
pmcid: PMC5746415
papertitle: Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade.
reftext: Jie Bai, et al. Oncotarget. 2017 Dec 15;8(66):110693-110707.
pmc_ranked_result_index: '133220'
pathway_score: 0.8852511
filename: oncotarget-08-110693-g001.jpg
figtitle: Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
year: '2017'
organisms: Homo sapiens
ndex: ccdeb330-df17-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5746415__oncotarget-08-110693-g001.html
  '@type': Dataset
  description: The inhibitors against target molecules are indicated, which could
    enhance antitumor responses in in mouse models when combined with PD-1/PD-L1 blockade.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK1
  - CXCL8
  - NT5E
  - FOXP3
  - CCL7
  - CCL5
  - MAPK10
  - MAPK11
  - MAPK3
  - MAPK9
  - CD274
  - MAPK8
  - BTLA
  - PDCD1LG2
  - GSK3B
  - PTEN
  - RAF1
  - GSK3A
  - HAVCR2
  - BRAF
  - ARAF
  - CTNNB1
  - HRAS
  - MAPK14
  - NRAS
  - PDCD1
  - MAPK13
  - MAPK12
  - IDO1
  - LAG3
  - TGFB3
  - TGFB2
  - TGFB1
  - JAK2
  - KRAS
  - AKT2
  - MAP2K1
  - B2M
  - AKT1
  - MAP2K2
  - AKT3
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: /ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CXCL8
  symbol: CXCL8
  source: hgnc_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: CD73
  symbol: CD73
  source: hgnc_alias_symbol
  hgnc_symbol: NT5E
  entrez: '4907'
- word: Foxp3
  symbol: FOXP3
  source: hgnc_symbol
  hgnc_symbol: FOXP3
  entrez: '50943'
- word: CCL5/7
  symbol: CCL7
  source: hgnc_symbol
  hgnc_symbol: CCL7
  entrez: '6354'
- word: CCL5/7
  symbol: CCL5
  source: hgnc_symbol
  hgnc_symbol: CCL5
  entrez: '6352'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: /ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: PD-L1/2
  symbol: PD-L1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: BTLA
  symbol: BTLA
  source: hgnc_symbol
  hgnc_symbol: BTLA
  entrez: '151888'
- word: PD-L1/2
  symbol: PD-L2
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1LG2
  entrez: '80380'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3B
  entrez: '2932'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: GSK-3
  symbol: GSK3
  source: bioentities_symbol
  hgnc_symbol: GSK3A
  entrez: '2931'
- word: TIM3
  symbol: Tim-3
  source: hgnc_alias_symbol
  hgnc_symbol: HAVCR2
  entrez: '84868'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: B-catenin
  symbol: beta-catenin
  source: hgnc_alias_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PD-1/PD-Ls
  symbol: PD-1
  source: hgnc_alias_symbol
  hgnc_symbol: PDCD1
  entrez: '5133'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: IDO
  symbol: IDO
  source: hgnc_prev_symbol
  hgnc_symbol: IDO1
  entrez: '3620'
- word: LAG3
  symbol: LAG3
  source: hgnc_symbol
  hgnc_symbol: LAG3
  entrez: '3902'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: JAK2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: B2M
  symbol: B2M
  source: hgnc_symbol
  hgnc_symbol: B2M
  entrez: '567'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
